# Immuneering Corp: Form 8-K, filed Aug 25, 2025

- Company: [Immuneering Corp](/companies/imrx.md) (CIK 1790340)
- Form: 8-K
- Filed: 2025-08-25
- Accepted by EDGAR: Aug 22, 2025, 20:58 ET
- Period: 2025-08-21
- Accession: 0001104659-25-081995
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1790340/000110465925081995/tm2524079d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1790340/000110465925081995/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1790340/000110465925081995/tm2524079d1_8k.htm

Filed Aug 25, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-081995. Last ingested by Listed: Oct 29, 2026, 18:24 ET. No prices; not investment advice.